Uncategorized

The healthcare fraud settlements under the False Claims Act last year more than tripled the amount from 2024.

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.

Hollingshead, the former CEO of Insulet, will lead BVI as it uses a $1 billion financing to support its global eye care business.

Debra Osteen, the behavioral healthcare provider’s CEO from December 2018 through March 2022, will take up the post again effective immediately. The company’s stock has declined nearly 70% over the past year.

Reporting Q4 and full year earnings on Wednesday, J&J executives hailed growth across the healthcare giant’s portfolio while standing fast on its talc lawsuit and tariffs.

The for-profit hospital giant has been aggressively divesting assets as it looks to pare down debt. With the sale of Crestwood Medical Center, CHS has passed its $1 billion target for divestitures, one analyst noted.

Attendance at the Biotech CEO Sisterhood’s annual photo of women leaders and allies in Union Square doubled this year. There’s still more work to do.

Recientemente, se puso en marcha el proyecto SpaceGenFish, cuya meta es demostrar que la cría de peces en el espacio puede ser una vía realista para obtener alimentos frescos y saludables en misiones espaciales de larga duración.   SpaceGenFish es un proyecto pionero lide …

  En 2026, la inteligencia artificial se ha integrado de forma estructural en la comunicación empresarial. Entre sus aplicaciones más influyentes destacan los agentes de voz con IA, que están redefiniendo cómo las empresas interactúan con clientes en un ent …